BHVN - Biohaven Ltd.
NEXT EARNINGS:
Mar 2, 2026
(in 5 days)
EPS Est: $-1.22
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$22.50
DETAILS
HIGH:
$42.00
LOW:
$11.00
MEDIAN:
$22.50
CONSENSUS:
$22.50
UPSIDE:
89.71%
Market Cap:
1.26B
Volume:
1,119,238
Avg Volume:
2,954,881
52 Week Range:
7.48-38.23
Sector:
Healthcare
Industry:
Biotechnology
Beta:
3.54
Last Dividend:
$N/A
Exchange:
NYSE
Country:
US
Employees:
256
IPO Date:
2022-09-23
EPS (TTM):
-9.28
P/E Ratio:
-4.03
Revenue (TTM):
N/A
Total Assets:
615.11M
Total Debt:
36.58M
Cash & Equiv:
99.13M
Rev Growth (5Y):
N/A
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
-192.0%
Debt/Equity:
0.09
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-11-10 | $-1.64 | $-1.91 | +14.1% | — | $375091 | — |
| 2025-08-11 | $-1.94 | $-1.94 | 0.0% | — | $412600 | — |
| 2025-05-12 | $-2.17 | $-1.67 | -29.9% | — | — | — |
| 2025-03-03 | $-1.85 | $-1.56 | -18.6% | — | — | — |
| 2024-11-12 | $-1.70 | $-1.70 | 0.0% | — | — | — |
| 2024-08-08 | $-3.64 | $-1.72 | -111.6% | — | — | — |
| 2024-05-09 | $-2.20 | $-1.50 | -46.7% | — | — | — |
| 2024-02-29 | $-1.81 | $-1.41 | -28.4% | — | — | — |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income | (846.42M) | (408.17M) | (570.28M) | (213.80M) | (118.67M) | (528.80M) |
| EPS | -9.28 | -5.73 | -12.75 | -5.97 | -3.31 | -10.91 |
| Total Assets | 615.11M | 513.21M | 661.78M | 142.06M | 111.50M | 344.26M |
| Total Debt | 36.58M | 30.88M | 33.60M | 3.24M | 3.60M | 0 |
| Cash & Equivalents | 99.13M | 248.40M | 204.88M | 76.06M | 82.51M | 316.73M |
| Operating Cash Flow | (582.45M) | (331.73M) | (297.69M) | (145.84M) | (75.96M) | (377.33M) |
| Free Cash Flow | (586.50M) | (334.77M) | (338.76M) | (146.78M) | (78.65M) | (379.87M) |
| FCF per Share | -6.43 | -4.70 | -7.57 | -4.10 | -2.20 | -7.83 |
| Book Value | 423.44M | 427.98M | 538.77M | 34.69M | 16.78M | (7.42M) |
| Cash & ST Investments | 485.99M | 381.82M | 465.34M | 76.06M | 82.51M | 316.73M |
| ROC Equity | -2.00 | -0.95 | -1.06 | -6.16 | -7.07 | N/A |